Plus Therapeutics Provides Highlights Regarding Leptomeningeal Metastases Acquisition and Topline Clinical Trial Data on the FORESEE Trial
Stock Information for PLUS THERAPEUTICS Inc.
Loading
Please wait while we load your information from QuoteMedia.